Our aim was to determine the risk factors associated with left ventricular hypertrophy (LVH) among 89 untreated children with primary hypertension (HTN). Clinic hypertension was confirmed by 24-hour ambulatory BP monitoring. Left ventricular mass index was calculated as LVM (g)/height (m) 2.7 , and LVH was defined as LVMI >95th percentile. Children with (n = 32) and without LVH (n = 57) were compared. Both obesity and systolic BP were independently associated with LVH, with a higher contribution by the BMI. Obesity contributed significantly, with a nearly 9 fold increased risk of LVH. There was evidence of effect modification by the presence or absence of obesity on the relationship between systolic BP and LVH, whereby the relationship existed mainly in the non-obese rather than the obese children. Hence, to achieve reversal of LVH, clinicians should take into account both BP control and weight management.
Introduction
Primary hypertension or essential hypertension (EH) can lead to cardiovascular changes in childhood, including subclinical hypertensive cardiomyopathy [1] [2] [3] , aortopathy 4 and vasculopathy 5, 6 . Left ventricular hypertrophy (LVH) as demonstrated by an increase in the left ventricular mass on an echocardiogram, is the most common surrogate marker of endorgan damage from EH 7-9 on an echocardiogram. Blood pressure (BP) levels alone cannot predict LVH and hence an echocardiogram is recommended in all children with hypertension 10 . Presence of LVH in adults with EH has been associated with impaired left ventricular systolic 11 and diastolic function 12 and thus overall worse cardiovascular morbidity and mortality [13] [14] [15] [16] [17] [18] [19] [20] . Hence, early detection and treatment of LVH in childhood is crucial to prevent cardiovascular events in adult life. Moreover, investigating end-organ damage in childhood can give further information on origins of subclinical hypertensive cardiomyopathy in humans.
Multiple risk factors, both genetic and environmental, have been associated with the LVH phenotype in the adults and children with EH. The LVH phenotype in children has been associated family history of EH 21 , with multiple markers of the child's BP such as diagnosis of hypertension 2 , systolic BP 22, 23 , diastolic BP 22, 24 , ambulatory BP [25] [26] [27] , nocturnal systolic BP 28, 29 , daytime systolic variability 29 , as well as with metabolic markers such as body mass index 22-24, 26, 30 , obesity 27, 31, 32 , body fatness 27 , lean tissue mass 27 , insulin resistance 31 , Creactive protein 23 , and microalbuminuria 23 .
Blood pressure levels have been shown to explain only about 40% of the variability in left ventricular mass amongst adults with untreated EH 33 . Controlling BP does decrease LVH in both adults and children with hypertension 34 but weight loss can also decrease LVH in those who do not have hypertension 35 . Among children with EH, it is unknown which has the greater influence on LVH, BP or weight. The aim of this study was to study the contributory factors associated with LVH phenotype in childhood-onset EH and determine individual contributions by weight and BP on LVH.
Methods

Institutional approval
The study was approved by the Institutional Committee for the Protection of Human Subjects at the University of Texas Health Science Center and Children's Memorial Hermann Hospital, Texas Medical Center. All participants and parents gave informed assent and consent, respectively for this study.
Patient Population
This was a single center, case-control study of children who were diagnosed with elevated BP prior to antihypertensive therapy. We prospectively enrolled children ages 9-18 years from our tertiary pediatric hypertension clinic whereby they were referred or recruited as follows: (1) Referral Study Population: These patients were referred to the clinic after detection of elevated BP from either an ambulatory setting by a primary care provider or an inpatient setting. (2) Recruited Study Population: Patients recruited by screening comprised a small proportion of patients in our clinic and were identified by systematic school-based screening for hypertension in students aged 11-18 years in Houston area public schools 36 . Patients recruited by these 2 methods i.e., school screening or referral as described above, have been reported to be similar in a prior publication 36 ; this was confirmed in our current dataset during this analysis. All enrolled children underwent further evaluation including ambulatory BP monitoring (ABPM) as described further below. Demographic and anthropometric data were collected on all subjects at study entry. Obesity was defined as body mass index (BMI) at or above 95 th percentile for age and gender.
Blood Pressure Protocol
Children with untreated newly diagnosed EH without any identifiable etiology for the hypertension were enrolled in the study. BP was reported as the participant's BP factored by their age, gender, and height-specific 95 th percentile (BP index). Hypertension status was evaluated by both clinic and ambulatory BP monitoring for 24 hours in all children as follows: Clinic hypertensive status was diagnosed when 3 separate measurements of systolic and/or diastolic BP > 95 th percentile for height, age and gender per Fourth Report 37 were recorded and elevated BP by Critikon oscillometric monitor (Tampa, FL) was determined at the first visit to the hypertension clinic. The hypertension in clinic was confirmed by manual auscultation with a mercury sphygmomanometer by trained personnel using methods recommended by the Fourth Report 37 . Clinic BP measurements considered the average of the last 3 of 4 BP measurements performed by oscillometric monitor after 5 minutes of rest. Prehypertension, stage I hypertension and stage II hypertension were classified per Fourth Report 37 . Children who were above the age of 5 years of age underwent an ambulatory BP monitoring (ABPM) using Spacelabs oscillometric monitors (Spacelabs, Inc., Redmond, WA). The children along with their families were instructed on avoidance of caffeinated beverages or supplements, any medications, herbal or over the counter products, smoking and alcohol for 24 hours prior to and during the ABPM. While on ABPM, BP was measured every 20 minutes for 24 hours. Children with casual hypertension but with 24-hour systolic BP and diastolic BP less than the pediatric 95 th percentile and BP load less than 25% were considered to have white coat hypertension. Children with mean 24-hour systolic BP or diastolic BP greater than the pediatric 95 th percentile or BP load (percentage of BP values exceeding the 95 th percentile for the 24-hour period) greater than 25% were considered to have ambulatory hypertension 38 .
Diagnosis of Essential Hypertension
Once hypertension was confirmed, the diagnosis of primary hypertension or EH was made by extensive evaluation per recommendations by the Fourth Working Group 37 including a urinary evaluation, blood tests, renal ultrasound and echocardiogram. Those children with congenital cardiac disease including bicuspid aortic valve were excluded from this study. Criteria for the diagnosis of EH were: (a) clinic BP elevation above the 95 th percentile on 3 previous occasions, (b) absence of secondary causes of hypertension and (c) no concurrent medication with the potential to raise BP (e.g., steroids, central stimulants).
Echocardiography and Vascular Ultrasound Protocol
All children underwent a transthoracic echocardiogram and a vascular ultrasound and the measurements were made in a manner blinded fashion. The reproducibility of measurements for both, echocardiogram and vascular ultrasound were determined by repeat assessments for ten values by the same sonographer and by 2 sonographers independently yielding kappa values of greater than 0.8. The echocardiographic studies were performed on all participants using an Acuson Sequoia 512 ultrasound machine (Siemens, PA, USA) by trained pediatric sonographers using a standard protocol to evaluate congenital cardiac disease 39 and LVH 40, 41 . Quantification of left ventricular mass (LVM) was made from 2-dimensionally guided M-mode measurements made during diastole of the left ventricular internal dimension, interventricular septal thickness, and posterior wall thickness according to methods established by the American Society of Echocardiography 40, 41 . The LVM was calculated using the equation reported by Devereux et al 42 . The LVM index (LVMI 2.7 ) was calculated by dividing LVM by height in meters to the 2.7 th power to minimize the effect of age, gender, ethnicity, and overweight status 43, 44 . For this study the LVH was defined as LVMI 38.6 g/m 2.7 , a value reported to represent the pediatric 95th percentile of LVMI 2.7 in normotensive healthy children [43] [44] [45] . Since after the age of 9 years, the quantiles of LVMI 2.7 vary little, we did not use these in our cohort of children since they were of ages 9 years and above 46 . Eccentric and concentric hypertrophy was defined similarly to previously reported literature 9 . The measurements of diastolic function (peak E and A velocities, E/A ratio, isovolumic relaxation time and deceleration times) were made by simultaneous transmitral and transaortic spectral Doppler flow velocities 41 . Carotid artery duplex ultrasound was performed by protocol to measure carotid intimal medial thickness (CIMT) by experienced vascular sonographers in a standard manner 47 . The thickest IMT complex of the far wall of the distal common carotid artery was measured in longitudinal B-mode section using a highresolution 8 MHz transducer. The right and left CIMT were averaged for the purpose of this study.
Statistical Analysis
The cases with LVH and no LVH were compared to one another. Data from the medical records was abstracted and tabulated. Mean (with standard deviations, SD) and medians (with interquartile ranges, IQR) for continuous variables were compared between groups using parametric (t-tests, ANOVA with posthoc Tukey) and non-parametric (Mann-Whitney, Kruskal Wallis) tests, respectively, depending on the distribution of the variable. Chi-square tests were used to compare categorical variables across groups. Multivariable logistic regression analyses were performed to assess odds of LVH relative to differences in demographic, anthropometric, BP, laboratory and vascular ultrasound parameters. Backward stepwise selection was utilized to optimize the regression model and calculate the odds ratios (OR) along with the 95% confidence interval (CI). All analyses was performed in STATA (v.11, College Station, TX). Statistical significance was assumed at a Type I error rate of 0.05.
Results
Children with EH (n = 89, males 65%, mean age 13.5 years, SD: 1.8 years) were enrolled for the study. Eight (9%) of the children were diagnosed with pre-hypertension, 23 (26%) with stage I hypertension and 58 (65%) with stage II hypertension in the clinic. LVH was detected in 32 (36%) of the children, with eccentric LVH in 25 (78%) and concentric LVH in 7 (22%) of these patients. Their demographic [ Table 1 ], anthropometric [ Table 1 ], BP parameters [ Table 2 ], laboratory [ Table 3 ], vascular ultrasound [ Table 3 ] and echocardiogram parameters [ Table 4 ] are summarized in tables.
In univariable analysis, LVH was significantly associated with weight/BMI but not with BP [ Tables 1 and 2 ]. The CIMT, triglyceride levels and isovolumic relaxation time were significantly higher among hypertensive children with LVH in comparison to those without [ Table 3 and 4]. Overall, the BMI z-scores were significantly higher in children with LVH (mean 1.9, SD: 0.6) than in those without LVH (mean 1.2, SD: 0.9; p=0.0002) [ Figure 1 , Table 1 ]. Additionally, univariable analysis of the degree of obesity showed that the odds of LVH was significantly higher in obese compared to normal weight children with EH (OR: 8.9; 95% CI: 2.3 -34.3; p = 0.002). A similar trend but of a lower magnitude was observed in overweight children compared to normal weight children with EH; however the trend failed to reach statistical significance (OR: 3.6; 95%CI: 0.8 -16.0; p = 0.096).
Various multivariable models were assessed to identify the factors associated with LVH. Multivariable logistic regression analyses were performed to assess odds of LVH relative to differences in demographic (age, gender, ethnicity), anthropometric (weight, BMI, BMI zscore), BP, laboratory and vascular ultrasound parameters. From all the variables selected only weight and/or BMI measurements were significantly associated with LVH. Adjusted for mean 24 hour ambulatory systolic BP, the BMI z-scores were significantly associated with LVH (OR: 5.69; 95% CI: 2.10 -15.44; p=0.001). Thus, for every incremental increased in standard deviation of the BMI z-score, the odds of LVH increased by more than 5-folds. The same models, also showed that for every 10 units increase in mean 24 hour ambulatory systolic BP, the odds of LVH approximately doubled (OR: 2.16; 95% CI: 1.04 -4.49; p = 0.039).
However, there was evidence of effect modification by the presence or absence of obesity on this relationship between systolic BP and LVH. Among the non-obese children, the mean 24 hour ambulatory systolic BP was significantly higher in children with LVH compared to those without LVH (mean 132 mmHg, SD 10 vs. mean 123 mmHg, SD 7, respectively; p=0.003) [ Figure 2 ]. In comparison, the obese children demonstrated similar levels of mean 24 hour ambulatory systolic BP between the two LVH groups (mean 122 mmHg, SD 9 vs. mean 120 mmHg, SD 9, respectively; p=0.659) ( Figure 2 ). Based on multivariable analysis, every 10 mmHg increase in mean 24 hour ambulatory systolic BP, the odds of LVH was much higher in the non-obese population (OR: 5.91; 95% CI: 1.18 -29.6; p = 0.030) than in the obese population (OR: 1.23; 95% CI: 0.44 -3.37; p = 0.693). This differential effect of obesity was also observed in the relationship of systolic BP measurements (in 10 mmHg increments) in the clinic and LVH, with a stronger association in obese (OR: 2.43; 95% CI: 1.07-5.52; p=0.033) than in non-obese (OR: 1.29; 95% CI: 0.67 -2.48; p=0.453) children with EH.
Discussion
In this study, we identified that among hypertensive children, BMI had a stronger independent effect on LVH than BP measures, both clinic systolic BP and mean 24 hour ambulatory systolic BP. Additionally, we identified the presence of effect modification by BMI on the association between LVH and BP.
Similar to previous reports 22-24, 27, 48 , and after robust analysis, both BMI and systolic BPs, were seen to contribute to the LVH phenotype in children with EH in our study. However, we have demonstrated that BMI has a higher contribution towards the presence of LVH. There was a nearly 9 fold increased risk in the development of LVH among obese children compared to normal weight children with EH. In our study, for every 10 mmHg increase in the 24 hour ambulatory mean systolic BP, the odds of LVH approximately doubled. Comparatively, the odds of LVH increased more than 5 fold for every unit increase in BMI z-score.
We further identified that in childhood onset EH, both obesity and systolic BP were independently associated with LVH. Interestingly, the relationship between systolic BP and LVH in our study was modified by the presence of obesity, whereby the relationship existed mainly in the non-obese rather than the obese children with EH [ Figure 2 ]. Thus, the systolic BP were significantly different between those with and without LVH in the non-obese hypertensive children, with higher systolic BP in those with LVH [ Figure 2 ]. However, the systolic BP were not significantly different between those with and without LVH among the obese hypertensive children [ Figure 2 ]. In one other study among African American adolescents, both obesity and high BP were found to be independently associated with elevated left ventricular mass index 32 . Our finding has implications on clinical management of these children and may indicate that even when the systolic BP is controlled, the child may continue to have LVH if he or she is obese, although this needs to be determined by a longitudinal study. It is possible that management of systolic BP alone in obese children would not result in complete resolution of LVH unless the weight is also controlled. Comparatively, in the non-obese children, BP control may provide a beneficial outcome with respect to resolution of their LVH.
We found that LVH phenotype was significantly associated with higher body size, triglycerides and arterial thickening. From previous studies, we know that LVH is prevalent among obese children and is seen in association, both with elevated BP 49, 50 and without elevated BP 27, 48, 51 . Therefore, it is not surprising that even in children with EH in our study, obesity plays a role in the development of LVH. In our previous study, upon a multivariate analysis, we demonstrated that left ventricular compliance indices correlated significantly with serum insulin levels in non-diabetic children with EH 1 . Obesity along with elevated triglycerides was seen in association with LVH in our current study indicating a potential role of cardiometabolic phenotype 51 in the development of LVH among children with EH.
We also found an abnormal diastolic distensibility or ventricular relaxation as evidenced by prolongation of the isovolumic relaxation time of the left ventricle was present in association with LVH in childhood onset EH. An alteration in left ventricular filling with myocardial fibrosis and ischemia has been demonstrated in adults with hypertension. This diastolic dysfunction is related to inappropriately high levels of left ventricular mass, disproportionate to the hemodynamic load predicted by the individual body size and cardiac load. Delayed left ventricular relaxation has been independently associated with concentric left ventricular geometry in hypertensive adults, including obese patients.
Our study was limited by the small sample size and lack of longitudinal data. Furthermore, our findings may not be generalizable due to a single-center design. We recommend a larger, multicenter study with longitudinal data to confirm our findings.
In our multiethnic study of hypertensive children, we identified that obesity and systolic BP were both independently associated with LVH. Hence, to achieve reversal of endorgan damage in children with EH, clinicians should take into account both BP control and weight management. Table 1 Demographic and laboratory profiles of with childhood onset essential hypertension with and without left ventricular hypertrophy Table 4 Echocardiographic profile in childhood onset essential hypertension with and without left ventricular hypertrophy Values are mean (with standard deviation) for all except as noted
